Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar
View ORCID ProfileLaith J. Abu-Raddad, View ORCID ProfileHiam Chemaitelly, View ORCID ProfileHoussein H. Ayoub, View ORCID ProfileSawsan AlMukdad, View ORCID ProfilePatrick Tang, Mohammad R. Hasan, View ORCID ProfilePeter Coyle, View ORCID ProfileHadi M. Yassine, View ORCID ProfileHebah A. Al-Khatib, Maria K. Smatti, View ORCID ProfileZaina Al-Kanaani, View ORCID ProfileEinas Al-Kuwari, View ORCID ProfileAndrew Jeremijenko, View ORCID ProfileAnvar Hassan Kaleeckal, Ali Nizar Latif, View ORCID ProfileRiyazuddin Mohammad Shaik, View ORCID ProfileHanan F. Abdul-Rahim, View ORCID ProfileGheyath K. Nasrallah, View ORCID ProfileMohamed Ghaith Al-Kuwari, Adeel A. Butt, View ORCID ProfileHamad Eid Al-Romaihi, View ORCID ProfileMohamed H. Al-Thani, Abdullatif Al-Khal, View ORCID ProfileRoberto Bertollini
doi: https://doi.org/10.1101/2022.01.18.22269452
Laith J. Abu-Raddad
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
4Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar
PhDHiam Chemaitelly
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
PhDHoussein H. Ayoub
5Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar
PhDSawsan AlMukdad
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
MScPatrick Tang
6Department of Pathology, Sidra Medicine, Doha, Qatar
MD PhDMohammad R. Hasan
6Department of Pathology, Sidra Medicine, Doha, Qatar
PhDPeter Coyle
7Hamad Medical Corporation, Doha, Qatar
8Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
9Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom
MDHadi M. Yassine
8Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
10Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhDHebah A. Al-Khatib
8Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
10Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhDMaria K. Smatti
8Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
10Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
MScZaina Al-Kanaani
7Hamad Medical Corporation, Doha, Qatar
PhDEinas Al-Kuwari
7Hamad Medical Corporation, Doha, Qatar
MDAndrew Jeremijenko
7Hamad Medical Corporation, Doha, Qatar
MDAnvar Hassan Kaleeckal
7Hamad Medical Corporation, Doha, Qatar
MScAli Nizar Latif
7Hamad Medical Corporation, Doha, Qatar
MDRiyazuddin Mohammad Shaik
7Hamad Medical Corporation, Doha, Qatar
MScHanan F. Abdul-Rahim
4Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar
PhDGheyath K. Nasrallah
8Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
10Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhDMohamed Ghaith Al-Kuwari
11Primary Health Care Corporation, Doha, Qatar
MDAdeel A. Butt
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
7Hamad Medical Corporation, Doha, Qatar
12Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York, USA
MBBS MSHamad Eid Al-Romaihi
13Ministry of Public Health, Doha, Qatar
MDMohamed H. Al-Thani
13Ministry of Public Health, Doha, Qatar
MDAbdullatif Al-Khal
7Hamad Medical Corporation, Doha, Qatar
MDRoberto Bertollini
13Ministry of Public Health, Doha, Qatar
MD MPH
Article usage
Posted January 24, 2022.
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar
Laith J. Abu-Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Patrick Tang, Mohammad R. Hasan, Peter Coyle, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A. Butt, Hamad Eid Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini
medRxiv 2022.01.18.22269452; doi: https://doi.org/10.1101/2022.01.18.22269452
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar
Laith J. Abu-Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Patrick Tang, Mohammad R. Hasan, Peter Coyle, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A. Butt, Hamad Eid Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini
medRxiv 2022.01.18.22269452; doi: https://doi.org/10.1101/2022.01.18.22269452
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2833)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12534)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4413)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2840)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4168)
- Nursing (220)
- Nutrition (615)
- Oncology (2195)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6754)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)